v3.26.1
Consolidated Statement of Changes in Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (loss)
Balance at beginning of period (shares) at Dec. 31, 2024   9,981,996      
Balance at beginning of period at Dec. 31, 2024 $ 179,084 $ 100 $ 114,564 $ 80,840 $ (16,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,197     3,197  
Other comprehensive income, net of tax 1,455       1,455
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting (shares)   (11,481)      
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting (183)   (183)    
Restricted common stock issued upon achievement of performance criteria (shares)   16,021      
Common stock options exercised (shares)   3,000      
Common stock options exercised 28   28    
Stock based compensation expense 68   68    
Cash dividends (3,598)     (3,598)  
Balance at end of period (shares) at Mar. 31, 2025   9,989,536      
Balance at end of period at Mar. 31, 2025 180,051 $ 100 114,477 80,439 (14,965)
Balance at beginning of period (shares) at Dec. 31, 2024   9,981,996      
Balance at beginning of period at Dec. 31, 2024 179,084 $ 100 114,564 80,840 (16,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 6,467        
Other comprehensive income, net of tax 1,536        
Balance at end of period (shares) at Jun. 30, 2025   9,991,997      
Balance at end of period at Jun. 30, 2025 183,462 $ 100 114,537 83,709 (14,884)
Balance at beginning of period (shares) at Dec. 31, 2024   9,981,996      
Balance at beginning of period at Dec. 31, 2024 $ 179,084 $ 100 114,564 80,840 (16,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock options exercised (shares) 16,500        
Balance at end of period (shares) at Dec. 31, 2025 9,617,245 9,617,245      
Balance at end of period at Dec. 31, 2025 $ 187,939 $ 96 110,315 89,995 (12,467)
Balance at beginning of period (shares) at Mar. 31, 2025   9,989,536      
Balance at beginning of period at Mar. 31, 2025 180,051 $ 100 114,477 80,439 (14,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,270     3,270  
Other comprehensive income, net of tax 81       81
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting (shares)   (539)      
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting (7)   (7)    
Common stock options exercised (shares)   3,000      
Common stock options exercised 33   33    
Stock based compensation expense 34   34    
Balance at end of period (shares) at Jun. 30, 2025   9,991,997      
Balance at end of period at Jun. 30, 2025 183,462 $ 100 114,537 83,709 (14,884)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,682     3,682  
Other comprehensive income, net of tax 1,657       1,657
Common stock repurchased (shares)   (135,252)      
Common stock repurchased (2,019) $ (1) (1,540) (478)  
Stock based compensation expense 33   33    
Balance at end of period (shares) at Sep. 30, 2025   9,856,745      
Balance at end of period at Sep. 30, 2025 186,815 $ 99 113,030 86,913 (13,227)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 4,271     4,271  
Other comprehensive income, net of tax 760       760
Common stock options exercised (shares)   10,500      
Common stock options exercised 118   118    
Common stock repurchased (shares)   (250,000)      
Common stock repurchased (4,036) $ (3) (2,844) (1,189)  
Stock based compensation expense $ 11   11    
Balance at end of period (shares) at Dec. 31, 2025 9,617,245 9,617,245      
Balance at end of period at Dec. 31, 2025 $ 187,939 $ 96 110,315 89,995 (12,467)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,755     3,755  
Other comprehensive income, net of tax 229       229
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting (shares)   (4,813)      
Surrender of restricted shares of common stock to satisfy the withholding taxes due upon vesting (89)   (89)    
Restricted common stock issued upon achievement of performance criteria (shares)   11,180      
Common stock options exercised (shares)   5,000      
Common stock options exercised 47   47    
Stock based compensation expense 4   4    
Cash dividends (1,011)     (1,011)  
Balance at end of period (shares) at Mar. 31, 2026   9,628,612      
Balance at end of period at Mar. 31, 2026 $ 190,874 $ 96 110,277 92,739 (12,238)
Balance at beginning of period (shares) at Dec. 31, 2025 9,617,245 9,617,245      
Balance at beginning of period at Dec. 31, 2025 $ 187,939 $ 96 110,315 89,995 (12,467)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 4,857        
Other comprehensive income, net of tax $ 444        
Common stock options exercised (shares) 21,000        
Balance at end of period (shares) at Jun. 30, 2026 9,650,231 9,650,231      
Balance at end of period at Jun. 30, 2026 $ 191,348 $ 97 110,454 92,820 (12,023)
Balance at beginning of period (shares) at Mar. 31, 2026   9,628,612      
Balance at beginning of period at Mar. 31, 2026 190,874 $ 96 110,277 92,739 (12,238)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,102     1,102  
Other comprehensive income, net of tax 215       215
Common stock awarded under the equity incentive plan (shares)   6,500      
Common stock options exercised (shares)   16,000      
Common stock options exercised 180 $ 1 179    
Common stock repurchased (shares)   (881)      
Common stock repurchased (18)   (10) (8)  
Stock based compensation expense 8   8    
Cash dividends $ (1,013)     (1,013)  
Balance at end of period (shares) at Jun. 30, 2026 9,650,231 9,650,231      
Balance at end of period at Jun. 30, 2026 $ 191,348 $ 97 $ 110,454 $ 92,820 $ (12,023)